Skip to Content

E613 E613 (Hydroxyzine Pamoate 25 mg)

Pill with imprint E613 E613 is Green, Capsule-shape and has been identified as Hydroxyzine Pamoate 25 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Hydroxyzine is used in the treatment of anxiety; sedation; allergic urticaria; allergies; nausea/vomiting and belongs to the drug classes antihistamines, miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy. Hydroxyzine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for E613 E613

Hydroxyzine pamoate 25 mg E613 E613
Hydroxyzine pamoate 25 mg E613 E613
Hydroxyzine pamoate 25 mg E613 E613

Hydroxyzine Pamoate

E613 E613
25 mg
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00185-0613 Eon Labs Inc.
62584-0739 Amerisource Health Services
00185-0674 Eon Labs Inc.
68084-0847 Amerisource Health Services
63874-0442 Altura Pharmaceuticals Inc. (repackager)
54868-2892 Physicians Total Care Inc. (repackager)
43063-0172 PDRX Pharmaceuticals Inc. (repackager)
53002-0621 Pharmedix (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.